Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Sarah Blagden

Associate Professor of Experimental Cancer Therapeutics

Research Summary

Investigating post-transcriptional mechanisms that drive cancer behaviour and researching novel cancer therapeutics for patients with advanced malignancies.

Biography

Following medical training and subsequent specialist training in Medical Oncology at Addenbrooke’s Hospital in Cambridge and the Royal Marsden Hospital, Sarah was awarded a CRUK Junior Clinician Scientist PhD fellowship in 1999 at Cambridge University and held a Clinical Fellowship at the Institute of Cancer Research’s Drug Development Unit.

She was appointed as Senior Lecturer and Honorary Consultant at Imperial College in 2006 and became Director of Imperial’s Early Cancer Trials Unit and established her laboratory studying the dysregulation of mRNA translation in cancer. She has been chief or principal investigator for a number of national and international clinical studies.

Group Members

James Chettle, Postdoctoral Researcher
Zinaida Dedeic, Postdoctoral Researcher
Fenella Gross, DPhil Student
Arussa Maan, Research Assistant and Lab Manager
Mai Abdel Mouti, Postdoctoral Researcher
Josephine Morris, Research Assistant
Hagen Schwenzer, Postdoctoral Researcher